TherapeuticsMD Inc (TXMD) is lower by Tuesday morning, with the stock decreasing -7.03% in pre-market trading to 2.38. TXMD's short-term technical score of 19 indicates that the stock has traded less bullishly over the last month than 81% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 141 out of 146 industries, TherapeuticsMD Inc ranks higher than 32% of stocks. TherapeuticsMD Inc has fallen 77.00% over the past month, closing at $11.22 on April 26. During this period of time, the stock fell as low as $2.27 and as high as $11.99. TXMD has an average analyst recommendation of Buy. The company has an average price target of $27.00.
TXMD has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on TXMD!